Your browser doesn't support javascript.
loading
USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.
Zhang, Deng Yong; Zhu, Yan; Wu, Qiong; Ma, Shuoshuo; Ma, Yang; Shen, Zheng Chao; Wang, Zhonglin; Sun, Wanliang; Zhou, Yong Chun; Wang, Dongdong; Zhou, Shuo; Liu, Zhong; Kwong, Lawrence N; Lu, Zheng.
Affiliation
  • Zhang DY; Department of General Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
  • Zhu Y; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Wu Q; Anhui Medical university, Hefei, 230000, Anhui, China.
  • Ma S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Ma Y; Cancer Biology Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.
  • Shen ZC; Department of pathology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
  • Wang Z; Department of General Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
  • Sun W; Department of pharmacy, Bengbu Medical College, No.2600 Donghai Road, Bengbu, 233000, Anhui, China.
  • Zhou YC; Department of General Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
  • Wang D; Department of General Surgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, Anhui, China.
  • Zhou S; Social Science Research Institute, Duke University, Durham, NC, 27708, USA.
  • Liu Z; Department of General Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
  • Kwong LN; Department of Radiotherapy, The First Affiliated Hospital of Bengbu Medical College, Anhui, China.
  • Lu Z; Department of General Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233000, Anhui, China.
Cell Death Dis ; 14(10): 669, 2023 10 11.
Article in En | MEDLINE | ID: mdl-37821462
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / Ubiquitin-Specific Proteases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2023 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / Ubiquitin-Specific Proteases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2023 Type: Article Affiliation country: China